Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MBX will rise by +9.09% over the next 2 Weeks and hit $36.26 by Tuesday, May 5, 2026. In that time frame, MBX's share price is expected to range between $34.75 and $37.70.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 6, 2026 | 35.11 | 36.49 | 37.97 |
| May 5, 2026 | 34.26 | 35.63 | 37.02 |
| May 4, 2026 | 34.13 | 35.43 | 36.73 |
| May 1, 2026 | 33.58 | 34.88 | 36.10 |
| Apr 30, 2026 | 34.47 | 35.80 | 37.05 |
| Apr 29, 2026 | 34.01 | 35.16 | 36.38 |
| Apr 28, 2026 | 33.09 | 34.31 | 35.65 |
| Apr 27, 2026 | 32.73 | 34.10 | 35.32 |
| Apr 24, 2026 | 32.37 | 33.56 | 34.76 |
| Apr 23, 2026 | 33.25 | 34.47 | 35.70 |
MBX shares rose +1.02% in Wednesday, April 22, 2026's trading session, rising from a previous close of $33.24 to move at $33.58. The stock demonstrated notable intraday movement (see MBX's key stats for a full breakdown), fluctuating between $32.33 and $34.12, a +5.52% trading range. While recent weeks have seen some volatility, MBX has managed to secure a +6.06% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 341.75K shares changing hands, 94.52K fewer than the previous session. This amounted to $11.48M in total market activity.
Will MBX Continue Its Upward Trend?
According to analyst ratings and projections for MBX, MBX Biosciences, Inc. Common Stock shares are anticipated to increase by +11.57%, potentially reaching $37.97 per share by May 6, 2026. Short-term technical indicators currently suggest a neutral sentiment for MBX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the MBX stock forecast, now is a good time to buy MBX stock because its current trading price is -7.97% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on MBX covering social and institutional perspectives.
MBX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MBX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 54.37% to 60.66%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 52.69%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 53.20%, maintains a neutral outlook for the long term. Insights into MBX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
MBX Biosciences Common Stock Short-Term Forecasts
MBX Forecast For Next 5 Days
Our algorithm anticipates MBX Biosciences Common Stock (MBX) stock could hit $28.23 by Apr 29, 2026. This represents a -15.95% rise from today's price, following a +18.29% change over the past five days.
MBX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for MBX Biosciences, Inc. Common Stock (MBX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $28.97, which would mean a -13.73% decrease from the current price of $33.58. Projections for this period range from a high of $34.99 to a low of $22.82.
MBX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for MBX Biosciences Common Stock's price over the next three months point to a rise. MBX stock is expected to peak at $42.49 on Jun 29, 2026 after potentially dipping to $30.23 on Apr 23, 2026. On average, MBX is likely to trade around $37.11 in the coming 90 days.
MBX Biosciences Common Stock Stock Forecast 2025
Based on our predictive models, MBX Biosciences Common Stock (MBX) is expected to trade between $30.23 and $55.17 throughout 2026. This would result in an average price of $39.24, potentially offering investors a +16.86% return from current levels.
MBX Biosciences, Inc. Common Stock Monthly Forecast 2026–2027
April 2026
According to our latest forecast models, MBX Biosciences, Inc. Common Stock (MBX) is positioned to show a strong performance in April 2026. The price is predicted to move between $30.23 and $37.69, settling at an average of $33.88. This could translate to a +0.89% gain.
May 2026
Based on current market signals, MBX Biosciences, Inc. Common Stock is projected to trend may 2026. We forecast a trading range from $31.19 to $41.30, with a likely average price of $36.89. Investors could expect a potential return of +9.86%.
June 2026
Our predictive algorithms indicate MBX Biosciences, Inc. Common Stock stock may see a shift in June 2026. The expected range spans $32.79–$42.49, with an average target of $38.10. This represents a positive outlook and a possible gain of +13.46%.
July 2026
Analyzing established trends, MBX Biosciences, Inc. Common Stock looks set to move in July 2026. Projections place the stock between $33.02 and $42.45, averaging around $37.68. This suggests a +12.21% gain from current levels.
August 2026
Market indicators suggest MBX Biosciences, Inc. Common Stock could experience notable changes during August 2026. Prices could fluctuate within $32.63 to $41.33, with a midpoint forecast of $37.08. The stock might deliver a +10.42% gain.
September 2026
Forecasting for September 2026, models estimate that MBX Biosciences, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $33.71 and $42.77, averaging $38.18. This signals a positive trajectory with potential returns around +13.70%.
October 2026
According to our latest forecast models, MBX Biosciences, Inc. Common Stock (MBX) is positioned to show a strong performance in October 2026. The price is predicted to move between $36.86 and $47.44, settling at an average of $41.77. This could translate to a +24.39% gain.
November 2026
Based on current market signals, MBX Biosciences, Inc. Common Stock is projected to trend november 2026. We forecast a trading range from $38.08 to $55.17, with a likely average price of $43.35. Investors could expect a potential return of +29.09%.
December 2026
Our predictive algorithms indicate MBX Biosciences, Inc. Common Stock stock may see a shift in December 2026. The expected range spans $37.63–$47.16, with an average target of $42.23. This represents a positive outlook and a possible gain of +25.76%.
January 2027
Analyzing established trends, MBX Biosciences, Inc. Common Stock looks set to move in January 2027. Projections place the stock between $38.00 and $46.12, averaging around $41.86. This suggests a +24.66% gain from current levels.
February 2027
Market indicators suggest MBX Biosciences, Inc. Common Stock could experience notable changes during February 2027. Prices could fluctuate within $38.49 to $47.55, with a midpoint forecast of $42.83. The stock might deliver a +27.55% gain.
March 2027
Forecasting for March 2027, models estimate that MBX Biosciences, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $41.54 and $50.79, averaging $46.29. This signals a positive trajectory with potential returns around +37.85%.
April 2027
According to our latest forecast models, MBX Biosciences, Inc. Common Stock (MBX) is positioned to show a strong performance in April 2027. The price is predicted to move between $42.38 and $51.67, settling at an average of $47.77. This could translate to a +42.26% gain.
MBX's history of dividends and stock splits also plays a role in long-term investor confidence.